MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

Clinical trial NCT05183074 · RECRUITING

Trial details

NCT number: NCT05183074
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Radiotherapy Side Effect Magnetic Resonance-linac Stereotactic Ablative RT Adaptive Radiotherapy Localised Disease Oligometastatic Disease

Start date: 2021-02-01
Primary completion: 2027-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.